Skip to main content
Phase III+: The University is open for expanded research operations; only authorized personnel will be admitted on campus. More info here.

The Clot Thickens: New Concepts for Treatment of Alzheimer’s Disease

Wednesday, October 30, 2019

6:00 PM Program | Reception to Follow

The Rockefeller University
Abby Aldrich Rockefeller Hall
1230 York Avenue at East 66th Street


Sidney Strickland, Ph.D.

Vice President for Educational Affairs
Research Professor

Patricia and John Rosenwald Laboratory of Neurobiology and Genetics


Richard P. Lifton, M.D., Ph.D.

President and Carson Family Professor
Laboratory of Human Genetics and Genomics

Alzheimer’s disease affects millions of people worldwide, with devastating physical, emotional, and financial consequences for patients and families. Research holds the best hope for the prevention and treatment of Alzheimer’s disease and other neurodegenerative disorders, such a Parkinson’s disease and stroke.

A known feature of Alzheimer’s disease is the presence of a toxic protein called beta-amyloid in the brain. Sid Strickland, a scientist at the forefront of research on neurovascular causes of Alzheimer’s, has studied largely unrecognized interactions between beta-amyloid and the blood clotting system. On October 30, Dr. Strickland will discuss these interactions and their role in neurovascular damage that drives disease. His work is helping to explain molecular mechanisms that disrupt brain function, with implications for the design of much-needed therapies and diagnostics.